Adherence programs have a credibility problem — broad claims, limited proof
Nimble’s latest case study takes a different approach: three programs, three therapeutic areas, third-party measurement.
The results across depression, dermatology, and women’s health:
- Up to 40% improvement in refill rates
- 57% lift in dermatologist visits and 49% lift in allergist visits from targeted digital outreach
- 2,031% lift in new-to-brand starts for a treatment-naive atopic dermatitis/psoriasis population
Nimble works through independent pharmacies — a largely untapped channel for pharma brands — to reach patients at the moment they’re most likely to act.
See the full data.
Offered Free by: NimbleRx
See All Resources from: NimbleRx
